Aethlon Medical received CDSCO approval to initiate an oncology trial and is running a trial in Australia.
5 reports, 2 independent
Updated Aug 16
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 5
- Developments
- 3
- Repetition
- 60%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Aethlon Medical received CDSCO approval to initiate an oncology trial and is running a trial in Australia.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Aethlon Medical is conducting an oncology study in Australia, treating a participant at Royal North Shore Hospital.Sub-event
Aethlon Medical is advancing its oncology trials in Australia and India.1 source
Trial update from San Diego regarding Aethlon Medical's clinical trials in Australia.1 source
Keep exploring
The entities involved
-
Aethlon Medical
Nothing else this week.
Coverage
Newest first; wire copies grouped- GuruFocus.comAethlon Medical Inc (AEMD) Q1 2026 Earnings Call Highlights: Strategic Focus on Australian ... Release Date: August 13, 2025 For the complete transcript of the earnings call, please refer to the full
- PR NewswireAethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2025, and Provides Corporate Update Australian Cancer Trial Advances with First Cohort Complete, Amended Protoc
- PR NewswireAethlon Medical, Inc. Announces Positive Data Safety Monitoring Board Review and Recommendation to Advance to Next Clinical Trial Cohort SAN DIEGO, July 15, 2025 /PRNewswire/ -- Aethlon Medical, Inc.
- Unknown outlet
- Unknown outlet